Sign In
Buy PFE
$27.05
+0.290 (+1.08%)
At Close: Aug 10, 2026
Pfizer (PFE) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:15am, Thursday, 30'th Jul 2026
Beyond analysts' top-and-bottom-line estimates for Pfizer (PFE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter en
Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials
07:48am, Thursday, 30'th Jul 2026
Pfizer said on Thursday its oral drug helped restore skin color in patients with a common form of vitiligo in two late-stage trials, paving the way for regulatory submissions seeking approval in
Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
06:45am, Thursday, 30'th Jul 2026
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from two Phase 3 trials evaluating the efficacy and safety of LITFULO once daily in patients with both activ
Europäische Kommission genehmigt Marktzulassung des an XFG angepassten COVID-19-Impfstoffs von Pfizer und BioNTech in der Europäischen Union
04:30pm, Wednesday, 29'th Jul 2026
Daten zeigten, dass die COVID-19-Impfstoffformulierung für das Jahr 2026-2027, die gegen die XFG-Variante gerichtet ist, eine starke Immunantwort gegen derzeit zirkulierende und neu auftretende Virus
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
04:30pm, Wednesday, 29'th Jul 2026
Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a strong immune response against contemporary circulating and emerging lineages More than five billion dos
Pfizer Stock Ahead of Q2 Earnings: To Buy or Not to Buy?
12:26pm, Wednesday, 29'th Jul 2026
Pfizer heads into Q2 earnings with expectations for growth in key products, COVID headwinds, and guidance updates that could shape its outlook.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Wednesday, 29'th Jul 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
5 High-Yielding Dividend Stocks for Retirees to Buy and Hold Forever
09:00am, Wednesday, 29'th Jul 2026
Retirees rebuilding income streams amid the current interest rate environment need dividend payers with cash-flow durability, not yield traps.
Boomers Are Buying 5 Quality High-Yield Stocks at Big Discounts Hand Over Fist
08:43am, Wednesday, 29'th Jul 2026
While many Baby Boomers have enjoyed a long bull market over the past 35 years, there is a point when income becomes more critical than stock appreciation.
Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing
06:45pm, Tuesday, 28'th Jul 2026
In the most recent trading session, Pfizer (PFE) closed at $25.25, indicating a +2.35% shift from the previous trading day.
Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
11:06am, Tuesday, 28'th Jul 2026
Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pfizer: Calling The Bottom - The Patent Cliff Is Real, But The Valuation Has Fallen Too Far
12:01pm, Monday, 27'th Jul 2026
I initiate Pfizer with a contrarian BUY rating and a $32 price target for 2026 Q3-Q4. PFE's non-COVID portfolio demonstrates resilience, with Padcev, Vyndamax, and new launches driving operational gro
Gabelli Funds LLC Lowers Position in Pfizer Inc. $PFE
03:54am, Monday, 27'th Jul 2026
Gabelli Funds LLC decreased its stake in shares of Pfizer Inc. (NYSE: PFE) by 11.8% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 508,600 shares o
3 Absurdly Cheap Dividend Stocks to Buy Before August
03:17pm, Sunday, 26'th Jul 2026
Far from "yield traps," these high-yield dividend stocks represent good value at current prices.
Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' July DiviDogs
06:27am, Sunday, 26'th Jul 2026
Verizon , Kinder Morgan, Regions Financial, and KeyCorp are the four buyable Barron's Better Bets Dogs, offering high, 'safest' dividends at fair prices. Analyst forecasts project net gains of 9.62% t
